<code id='49198FCDAD'></code><style id='49198FCDAD'></style>
    • <acronym id='49198FCDAD'></acronym>
      <center id='49198FCDAD'><center id='49198FCDAD'><tfoot id='49198FCDAD'></tfoot></center><abbr id='49198FCDAD'><dir id='49198FCDAD'><tfoot id='49198FCDAD'></tfoot><noframes id='49198FCDAD'>

    • <optgroup id='49198FCDAD'><strike id='49198FCDAD'><sup id='49198FCDAD'></sup></strike><code id='49198FCDAD'></code></optgroup>
        1. <b id='49198FCDAD'><label id='49198FCDAD'><select id='49198FCDAD'><dt id='49198FCDAD'><span id='49198FCDAD'></span></dt></select></label></b><u id='49198FCDAD'></u>
          <i id='49198FCDAD'><strike id='49198FCDAD'><tt id='49198FCDAD'><pre id='49198FCDAD'></pre></tt></strike></i>

          entertainment

          entertainment

          author:focus    Page View:84526
          Two Vertex buidings in the Seaport District
          David L Ryan/Globe Staff

          When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

          Now, Vertex may be on the move again.

          advertisement

          With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more
          ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?
          ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

          SusanGalbraith,AstraZeneca’sheadofcancerresearchanddevelopment,speaksataSTATeventin2023.MarieMillerf

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

          3:16FILE-CardinalMatteoZuppi,headoftheCEI(ItalianConferenceofBishops),welcomesparishionersafterceleb